1. Home
  2. Analysis
  3. Cipro
  4. Ofev

Cipro and Ofev drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cipro (ciprofloxacin hydrochloride) and Ofev (nintedanib esylate). Common drug interactions include cough among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Cipro and Ofev. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.

What is Ofev?

Ofev has active ingredients of nintedanib esylate. eHealthMe is studying from 24,791 Ofev users. Check the latest studies of Ofev.

On Aug, 09, 2026

19 people who take Cipro and Ofev together, and have interactions are studied.

Cipro and Ofev drug interactions.

What are the common drug interactions of Cipro and Ofev, by gender? *:

female:

  1. Cough
  2. Diarrhoea
  3. Nausea (feeling of having an urge to vomit)
  4. Vomiting
  5. Fatigue (feeling of tiredness)
  6. Dizziness
  7. Weight decreased
  8. Headache (pain in head)
  9. Decreased appetite
  10. Dehydration (dryness resulting from the removal of water)

male:

  1. Diarrhoea
  2. Dyspnoea (difficult or laboured respiration)
  3. Kidney infection
  4. Localised oedema (fluid retention in a particular part of the body)
  5. Nausea (feeling of having an urge to vomit)
  6. Oedema peripheral (superficial swelling)
  7. Peripheral swelling
  8. Pleural disorder
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

What are the common drug interactions of Cipro and Ofev, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Cough
  2. Diarrhoea
  3. Flatulence (flatus expelled through the anus)
  4. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  5. Pain
  6. Blood pressure increased
  7. Discomfort
  8. Dry throat
  9. Faeces discoloured
  10. Idiopathic pulmonary fibrosis (chronic lung disease)

What are the existing conditions these people have? *

  1. Idiopathic Pulmonary Fibrosis (chronic lung disease): 17 people, 89.47%
  2. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 15.79%
  3. Wheezing (a high-pitched whistling sound made while you breath): 1 person, 5.26%
  4. Pneumonia: 1 person, 5.26%
  5. Mycobacterial Infection: 1 person, 5.26%
  6. Infection: 1 person, 5.26%
  7. Enteritis (inflammation of the small intestine): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Cipro and Ofev?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cipro and Ofev:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ofev:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cipro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ofev and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ciprofloxacin hydrochloride and nintedanib esylate (the active ingredients of Cipro and Ofev, respectively), and Cipro and Ofev (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.